Skip to main content

Clinical aspects on presynaptic noradrenaline metabolism

  • Conference paper
  • 52 Accesses

Part of the book series: Journal of Neural Transmission ((NEURAL SUPPL,volume 34))

Summary

In healthy subjects, similar absolute increments in plasma noradrenaline (NA) and dihydroxyphenylglycol (DOPEG) were observed in response to upright posture or isoprenaline infusion. Blockade of neuronal uptake by desipramine abolished these plasma DOPEG responses and reduced plasma DOPEG per se. In essential hypertensives we found higher than normal plasma DOPEG levels at any given plasma NA. Evidence is provided that both the desipramine-sensitive and -resistant pool of plasma DOPEG contribute to this hypertensive-normotensive difference.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Cohen MD, Finberg J, Dibner-Dunlap M, Yuih SN, Thames MD (1990) Effects of desipramine on peripheral sympathetic nerve activity. Am J Physiol 258: R876–882

    PubMed  CAS  Google Scholar 

  • Eisenhofer G, Goldstein DS, Kopin IJ (1989) Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. Clin Sci 76: 171–182

    PubMed  CAS  Google Scholar 

  • Esler M, Jennings G, Korner P, Willet I, Dudley F, Hasking G, Anderson W, Lambert G (1988) Assessment of human sympathetic nervous activity from measurements of norepinephrine turnover. Hypertension 11: 3–20

    PubMed  CAS  Google Scholar 

  • Goldstein DS, Horwitz D, Keiser HR, Polinsky RJ, Kopin IJ (1983) Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d, l-[3H]isoproternol kinetics in essential hypertension. J Clin Invest 72: 1748–1758

    Article  PubMed  CAS  Google Scholar 

  • Graefe K-H, Henseling M (1983) Neuronal and extraneuronal uptake and metabolism of catecholamines. Gen Pharmacol 14: 27–33

    Article  PubMed  CAS  Google Scholar 

  • Halbrügge T, Gerhardt T, Ludwig J, Heidbreder E, Graefe K-H (1988) Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress. Life Sci 43: 19–26

    Article  PubMed  Google Scholar 

  • Head RJ (1989) Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 26: 1–20

    PubMed  CAS  Google Scholar 

  • Izzo JL, Thompson DA, Horwitz D (1985) Plasma dihydroxyphenylglycol ( DHPG) in the in vivo assessment of human neuronal norepinephrine metabolism. Life Sci 58: 1033–1038

    Google Scholar 

  • Kopin IJ (1985) Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333–364

    PubMed  CAS  Google Scholar 

  • Ludwig J, Gerhardt T, Halbrugge T, Walter J, Graefe K-H (1988) Plasma concentrations of noradrenaline and 3,4-dihydroxyphenylethyleneglycol under conditions of enhanced sympathetic activity. Eur J Clin Pharmacol 35: 261–267

    Article  PubMed  CAS  Google Scholar 

  • Ludwig J, Halbrugge T, Vey G, Walter J, Graefe K-H (1989) Haemodynamics as a determinant of the pharmacokinetics of and the plasma catecholamine responses to isoprenaline. Eur J Clin Pharmacol 37: 493–500

    Article  PubMed  CAS  Google Scholar 

  • Ludwig J, Gerhardt T, Halbrugge T, Walter J, Heidbreder E, Graefe K-H (1990) Effects of nisoldipine on stress-induced changes in haemodynamics and plasma catecholamines in normotensives and hypertensives. J Human Hypertens 4: 693–701

    CAS  Google Scholar 

  • Ludwig J, Gerlich M, Halbrugge T, Graefe K-H (1991) Plasma norepinephrine and dihydroxyphenylglycol in essential hypertension. Hypertension 17: 546–552

    PubMed  CAS  Google Scholar 

  • Szabo B, Schultheiss A (1990) Desipramine inhibits sympathetic nerve activity in the rabbit. Naunyn-Schmiedebergs Arch Pharmacol 342: 469–476

    CAS  Google Scholar 

  • Trendelenburg U, Bonisch H, Graefe K-H, Henseling M (1980) The rate constants for the efflux of metabolites of catecholamines and phenethylamines. Pharmacol Rev 31: 179–203

    Google Scholar 

  • Vlachakis ND, Alexander N (1981) Plasma catecholamines and their major metabolites in spontaneously hypertensive rats. Life Sci 29: 467–472

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag

About this paper

Cite this paper

Ludwig, J., Halbrügge, T., Graefe, KH. (1991). Clinical aspects on presynaptic noradrenaline metabolism. In: Bönisch, H., Graefe, KH., Langer, S.Z., Schömig, E. (eds) Recent Advances in Neuropharmacology. Journal of Neural Transmission, vol 34. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9175-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9175-0_9

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82300-2

  • Online ISBN: 978-3-7091-9175-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics